EU Clinical Trial Information System (CTIS)

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

CSR-D5890L00008_final.pdf

The purpose of the study is to compare the efficacy of a flexible dose of Symbicort (budesonide/formoterol) with conventional stepwise best standard treatment in patients with persistent asthma.

MONO: Symbicort® Single inhaler Therapy and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults

CTIS Number

EudraCT Number

NCT ID

Patient Level Data

Therapeutic Area

Research Site

A comparison of the efficacy of Symbicort® Single inhaler Therapy (Symbicort Turbuhaler® 160/4.5 mg 1 inhalation b.i.d. plus as-needed) and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults. A randomized, open, parallel-group, multicentre 26-weeks study

MONO: Symbicort® Single inhaler Therapy and conventional best standard treatment for the treatment of persistent asthma in adolescents and adults

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Research Site

Documents available

http://www.astrazeneca.com/node/emailtriage.aspx

CSR Synopsis

Trial Results Summaries

Contacts

Contact

Investigators

Principal Investigator